6-K 1 a7517t.htm DIRECTOR/PDMR SHAREHOLDING a7517t

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
 
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of March 2023
 
Commission File Number 001-15170
 
GSK plc
 
(Translation of registrant's name into English)
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
 
(Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
 
 
GSK plc (the ‘Company’)
 
Transaction notification
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
a)
Name
Mr Urs Rohner
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’)
ISIN: GB00BN7SWP63
b)
Nature of the transaction
Purchase of 490 Ordinary Shares
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
£14.066
490
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
e)
Date of the transaction
2023-03-20
f)
Place of the transaction
London Stock Exchange (XLON)
 
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
a)
Name
Charles Bancroft
b)
Position/status
Senior Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares (‘ADSs’)
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 1,861 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$34.5033
1,861
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
e)
Date of the transaction
2023-03-20
f)
Place of the transaction
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
a)
Name
Dr Hal Barron
b)
Position/status
Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares (‘ADSs’)
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 242 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$34.5033
242
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
e)
Date of the transaction
2023-03-20
f)
Place of the transaction
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
a)
Name
Dr Anne Beal
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares (‘ADSs’)
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 241 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$34.5033
241
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
e)
Date of the transaction
2023-03-20
f)
Place of the transaction
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
a)
Name
Dr Hal Dietz
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares (‘ADSs’)
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 241 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$34.5033
241
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
e)
Date of the transaction
2023-03-20
f)
Place of the transaction
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
a)
Name
Dr Jesse Goodman
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares (‘ADSs’)
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 241 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$34.5033
241
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
e)
Date of the transaction
2023-03-20
f)
Place of the transaction
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
a)
Name
Elizabeth (Liz) McKee Anderson
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares (‘ADSs’)
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 473 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$34.5033
473
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
e)
Date of the transaction
2023-03-20
f)
Place of the transaction
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them (‘PCA’)
a)
Name
Dr Vishal Sikka
b)
Position/status
Independent Non-Executive Director
c)
Initial notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares (‘ADSs’)
ISIN: US37733W2044
b)
Nature of the transaction
Purchase of 838 ADSs
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$34.5033
838
 
 
 
 
 
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
 
e)
Date of the transaction
2023-03-20
f)
Place of the transaction
New York Stock Exchange (XNYS)
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
 
GSK plc
 
 
(Registrant)
 
 
 
Date: March 21, 2023
 
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
 
Victoria Whyte
 
 
Authorised Signatory for and on
 
 
behalf of GSK plc